Role of TMEM-143 in Glucose Homeostasis-Implications in the Pathogenesis of Type-2 Diabetes
ISEF · 2022 Biomedical and Health Sciences
Overview
TMEM-143 (Transmembrane protein 143) human gene is located in the Chr19q13.33 chromosomal region, which is known to be associated with the risk of type-2 diabetes and cancer. TMEM-143 gene is translated into a protein of unknown function, predicted to contain a mitochondrial signal sequence, and to reside as an integral membrane protein (dual-pass protein) in the mitochondria. Screening of normal human tissues by RT-PCR revealed a high expression of the TMEM-143 gene in metabolic tissues such as the skeletal muscle tissue (data not shown). In this study, we sought to elucidate the TMEM-143 expression pattern, subcellular localization, and function in myoblasts C2C12 and pre-adipocytes 3T3-L1. RT-PCR and western blot revealed that TMEM-143 expression increased during the differentiation process of 3T3 and C2C12 into adipocytes and myotubes respectively. We found that TMEM-143 expression level can be modulated by anti-diabetic drugs such as Insulin, Rosiglitazone, and Metformin. Confocal fluorescence imaging (CFI) revealed that TMEM-143 is localized in mitochondria, plasma membrane, and nucleus. Furthermore, CFI uncovered that TMEM-143 co-localized with glucose transporter type 4 (GLUT-4). TMEM-143 silencing with siRNA did not induce mitochondrial dysfunction (cell death) but induced a decrease in both GLUT-4 and PAKT levels, suggesting that the GLUT-4 associated AKT-dependent signaling pathway was affected. Subsequently, the glucose uptake by 3T3 or C2C12 was significantly inhibited by more than 50%. TMEM-143 may play a physiological role in glucose homeostasis and merits further investigation.
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2018
Identification of Novel Drivers of Insulin Resistance and Type 2 Diabetes in the Skeletal Muscle Tissue of Non-Obese Individuals Using a Multi-Omics Approach
ISEF · 2023
Possible Use of MicroRNA-488 as a Biomarker for Bad Prognosis in Type 2 Diabetes
ISEF · 2015
miRNAs as Biomarkers of IAPP-induced Inflammation in Type 2 Diabetes
ISEF · 2014
Enhancing Pancreatic Islet Function in an Obese Mouse Model
JSHS · 2023
Potential Use of MicroRNA-488 as a Biomarker for Type 2 Diabetes
ISEF · 2021
Immunohistochemical Analysis Suggests a Role for Tmem131 in Thymic Epithelial Cell Differentiation
ISEF · 2021
Abnormalities of PTPN2 Increases BETA-cell Apoptosis in PP2-Beta Cells Derived from hESCs
ISEF · 2017
Identification of Type 2 Diabetes Mellitus Related Single Nucleotide Polymorphisms in the Middle East with Comparative and Epigenetic Analysis
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair